OSN SuperSite - The Voice of Ophthalmology - latest news and articles from Ocular Surgery News; Ophthalmic Surgery, Lasers and Imaging; Journal of Refractive Surgery; and Pediatric Ophthalmology and Strabismus This report stated: "Patients treated with intravitreal triamcinolone or a laser for persistent diabetic macular edema showed “no statistically significant improvement from baseline” at the 1–year follow-up, said Zdenek Gregor, MD, at the French Society of Ophthalmology meeting.
"Patients experienced an initial improvement in best corrected visual acuity and a reduction of macular thickness. However, by 1 year, results returned to near baseline and there was no statistically significant improvement in either group, he said.
"'The results were inconclusive or rather negative. Intravitreal triamcinolone up to 1 year did not improve BCVA, did not reduce macular thickness or volume' Dr. Gregor said. 'Intravitreal triamcinolone is unlikely to improve visual acuity in any lasting fashion.'"
No comments:
Post a Comment
Leave a Comment or Question: